Fig. 1From: Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literatureChest CT-scan performed at diagnosis in October 2013 (a), in May 2014 following first line chemotherapy (b), in April 2015 at tumor progression following radiotherapy (c), in January 2016 before starting immunotherapy (d), in May 2016 during immunotherapy (e) and in December 2017 following 38 cycles of immunotherapy administration (f)Back to article page